—IEX
— • —
$201.09
P/E
31.36
PEG
—
FCF Yield
—
Rev Growth YoY
+577.0% YoY
Gross Margin
4452.0%
Health Score
6/10
D/E Ratio
0.45
Confidence
LOW
Business Snapshot
The company behind this ticker operates in an unspecified sector and industry, making a full business description impossible from the payload alone. What is clear is that it trades at $201.09 per share and carries a Price/Sales ratio of 4.32x alongside a P/E of 31.36x, suggesting a commercially active, revenue-generating business. Without a confirmed market cap figure, the size tier cannot be definitively assigned, though the valuation multiples are consistent with a small-to-mid cap growth-oriented firm.
Financial Health
**Score: 6/10** The balance sheet shows a conservative debt posture, with a Debt/Equity ratio of 0.45x, well below levels that typically signal financial stress. Liquidity appears solid, with a Current Ratio of 2.86x, meaning the company holds nearly three dollars of current assets for every dollar of near-term obligations...
Risk Assessment
- **DATA QUALITY:** Gross margin of 4,452% and net margin of 1,398% are statistically implausible for most industries and likely indicate data anomalies or accounting classifications that distort true profitability assessment. - **EARNINGS DETERIORATION:** Earnings growth of -350.0% YoY directly contradicts the 577.0% revenue surge, signalling that cost structures or one-time charges are consuming revenue gains. - **VALUATION PREMIUM:** P/E of 31.36x sits approximately 25% above the sector average of 25x with no PEG or DCF support to justify the premium. - **TECHNICAL WEAKNESS:** A confirmed death cross (50-day MA crossing below 200-day MA) is a classically bearish technical signal, compounded by a bearish MACD reading. - **FCF ABSENCE:** Free cash flow data is unavailable, removing the most critical measure of whether the business actually converts earnings into real cash — a fundamental blind spot. ---...